Search

everythinglearnresearchcommunity

for

Search:↓

Addressing burnout and compassion fatigue in healthcare is crucial for improving job satisfaction and care quality.

Sodium valproate can worsen psoriasis-like skin conditions.

Remote photobiomodulation improves brain injury outcomes and behavior in rats.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Systematic symptom assessment helps prioritize care for children undergoing cancer treatment.

Suppressing ODC activity reduces tumor growth in hair follicles.

A group has developed therapies that show promise for treating cancer and various other conditions.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Keloids significantly reduce quality of life, and treating symptoms should be prioritized.

Addressing psychosocial symptoms can improve outcomes for people with Hidradenitis Suppurativa.

People with hidradenitis suppurativa who are more resilient tend to have better quality of life and less anxiety and depression.

No single method is best for quitting smoking; it depends on individual preferences and health.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

Treatments for urinary symptoms often cause ejaculatory problems.

The pandemic increased stress-related skin conditions and those affected by behavior changes.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

SJS and TEN can cause long-term organ damage and psychological issues beyond skin and eye problems.

Trichotillomania in children is a sign of emotional distress needing tailored treatment and family support.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

New treatments for alcohol, opioid, and cannabis addiction include medications, therapy, and personalized plans.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

Power-enhancing drugs can cause mood swings, aggression, anxiety, and physical side effects, questioning their overall benefits.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.